Waiv, formerly Owkin Dx, a company advancing AI precision testing, today announced that two of its AI precision tests, RlapsRisk ® BC for breast cancer prognostic risk profiling ...
OREM, UT, UNITED STATES, March 2, 2026 /EINPresswire.com/ — Techcyte, a leading provider of AI-powered digital diagnostics for anatomic and clinical pathology ...
First-and-only test of its kind approved under new European Union regulations expands access to personalized cancer care for patients across the EU This in vitro diagnostic (IVD) assay, which has been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results